Amyloid peptide (Aβ) is the major component of senile plaques found in the brain of patient of Alzheimer's disease. β-amyloid peptide (25-35) (Aβ25-35) is biologically active fragment of Aβ. The three-dimensional structure of Aβ25-35 in aqueous solution with 50% (vol/vol) TFE determined by NMR spectroscopy previously adopts an α-helical conformation from Ala 30 to Met
Introduction
The aggregation of α-helix-rich proteins into beta-sheetrich amyloid fibrils is associated with fatal diseases, such as Alzheimer's disease and prion disease. The mechanism of this disease associates with progressive deposition of these amyloid fibrils to form senile plaques. 1, 2 During an aggregation process, protein secondary structural elements, α-helices undergo conformational changes to β-sheets. 3, 4 The main component of plaques found in human patients suffering from Alzheimers disease is a small peptide, β-amyloid A4 (Aβ), of 39-43 amino acids derived from amyloid A4 precursor protein (APP) by proteolytic cleavage. 1, 6 There are growing interests in neurotoxicity of this hydrophobic peptide Aβ and progressive cerebral deposition of Aβ appears to be at least the necessary event in the pathogenesis of the disease. 7 Aβ includes 28 residues corresponding to an extra cellular domain, and the rest of the protein constitutes a transmembrane region. 8 Aβ25-35 having an amino acid sequence of Gly-Ser-Asn-Lys-GlyAla-Ile-Ile-Gly-Leu-Met that contains both hydrophilic domain (Ser 26 -Gly 29 ) and six hydrophobic residues of transmembrane region has been reported to have biologically active fragment and contribute to aggregation. [9] [10] [11] [12] Also it was reported that the biological activity of Aβ25-35 is not reduced as compared to full-length of Aβ. [9] [10] [11] [12] Various high-resolution structural studies have been executed using nuclear magnetic resonance (NMR) spectroscopy upon full length, N-terminal or C-terminal fragments of Aβ under a variety of conditions. [13] [14] [15] [16] [17] [18] [19] Circular dichroism (CD) spectroscopy and infrared (IR) spectroscopy studies of this peptide and its fragment suggest that the secondary structure content of these peptides is strongly dependent on solution conditions. [20] [21] [22] [23] [24] [25] [26] [27] It has been proposed by CD spectroscopy that Aβ exhibits pH-and concentration-dependent α-helix ↔ β-sheet transition 24 and 25-35 fragments shows lipid-induced reversible random-coil ↔ β-sheet transition. 20, 21 This conformational transition with concomitant peptide aggregation is a possible mechanism of plaque formation.
According to our previous CD studies, in SDS micelle has a single minimum at 215 nm, which is the characteristic of the β-sheet structure while Aβ25-35 has a random coil conformation in aqueous buffer.
13 Surprisingly, it adopts α-helical conformation without aggregation in the presence of trifluoroethanol (TFE). TFE is known as a secondary-structure-inducing agent. Since influence of TFE on the conformation of peptides is not well understood, characterization of the effects of TFE is important to understand protein folding. Here, in order to gain more insight into the mechanism of α-helix formation of Aβ25-35 peptide in TFE, which particularly stabilizes α-helical conformation, we studied the secondary-structural elements of the Aβ25-35 peptide in TFE aqueous solution by molecular dynamics simulations.
Experimental Section
All of the calculations were performed using CHARMm program. [28] [29] [30] [31] The molecular dynamics simulation was performed using explicit solvent molecules at a temperature of 300 K for the time length of 1.5 ns. The starting conformation of Aβ25-35 was taken from the restrainedminimized average structure determined in our previous work by NMR experiments that were conducted in 50% aqueous TFE solution. 13 In order to solvate this structure completely, a cubic box consisting of 500 water molecules and 137 TFE molecules, with a length of 31 Å in each dimensions was created. This box was equilibrated by 100ps molecular dynamics after randomly placing of solvent molecules. The parameters for the polypeptide chain in peptide and TIP3P water model for simulating water molecules were used from the standard parameter set version 19 supplied with CHARMm. 32, 33 Additional parameters for TFE molecules were taken from the previous work. [34] [35] [36] The 'extended atom' representation was used for TFE molecules, so that only hydrogen atoms having possibility of involving hydrogen bonds were included in the calculations. Periodic boundary conditions were applied after solvation of the peptide. Dielectric constant was set to unity and the nonbonded distance cutoff was set to 12 Å. The nonbonded interactions were smoothed between 8 and 11 Å using switch function. The starting conformation of Aβ25-35 was solvated in the TFE/H 2 O cubic box and a number of solvent molecules with any atom closer than 2.6 Å to any of the peptide atoms were removed, leaving a total of 446 water molecules and 110 TFE molecules in the system. Then, 500 steps of steepest decent minimization were carried out with the peptide harmonically constrained to its original coordinates to eliminate any unfavorable close contacts and geometric strain in the system. During the first 40ps of MD simulation, the peptide was harmonically constrained to its original position, allowing the solvent molecules to equilibrate further. The complete system was gradually heated to 300 K during the first 30ps and equilibrated for 10ps. The constraints on the peptide were removed after the first 40ps and the system was equilibrated for 30ps. The intermediate structures generated during MD simulation were saved every 0.5ps. All covalent bonds containing the hydrogen atoms were constrained using SHAKE algorithm 37 with the tolerance of 10 −10 Å. Verlet algorithm 38 was used for the MD simulation using a time step of 1fs. The total length of the simulation was 1.5 ns.
Results and Discussion

RMSD as a function of time in MD simulations.
According to our previous CD study, Aβ25-35 has a random coil conformation in aqueous buffer, while it adopts α-helical conformation without aggregation in the presence of TFE.
13 Figure 1 shows the superposition of 20 low energy structures on the backbone atoms from Ala 30 to Leu 34 of Aβ25-35 in TFE/water (1 : 1, vol/vol) solution determined by NMR spectroscopy and they converged well. Lowest energy structure was utilized for the starting structure of MD simulation. 13 Figure 2 shows the RMS deviations from the starting structure during 1.5 ns MD simulations. The RMSD values of the protein backbone atoms between the structures resulting from the simulations and the starting structure are compared in Figure 2 . In the simulations a rapid initial increase of the RMSD was observed during the first 100 ps. RMSD values in a TFE/water mixed solvent tended to be relatively constant after 100ps including heating and equilibrium periods. All structures were fit well against the equilibrated structure obtained after the heating stage in order to remove effects from translocational and rotational shifts. The RMSD values of the all heavy atoms including the side chain atoms are shown in gray lines and are slightly higher than those of backbone atoms. This implies that the side chains in Aβ25-35 show bigger structural flexibilities than the backbone atoms during the MD simulation.
Comparison of results of NMR experiment and MD simulation. Table 1 shows the comparison of the distance between peptide amide protons and Ca protons from NMR experiments and MD simulations. Starting structure of Aβ25-35 has an a-helical structure from Ala30 to Met35. NOE intensities can be divided into three classes (strong, medium, and weak) with distance ranges of 1.8-2.7, 1.8-3.5, and 1.8-5.0 Å, respectively. α-helical conformations are retained during the MD simulations but the Met 35 at the Cterminus fluctuates a lot. dαN(i,i+3) connectivity for Ile 31 CαH-Leu 34 NH and dαN(i,i+4) connectivity for Ala 30 CαH-Leu 34 NH, which was the characteristics for α-helix were retained during the MD simulations as shown in this table. During the simulations the flexibilities of the C-terminal part was increased and distance between Ile 32 and Met 35 becomes longer because of the structural fluctuations at C-terminus.
Dihedral angles Φ, Ψ plots. The fluctuations of the backbone dihedral angles are shown in Figure 3 . The scattering of the Φ, Ψ angles in plots can be used as an information about the fluctuations of the secondary structural elements. For each residue, the 200 structures collected during the MD simulations are represented in the figure. Figure 3 shows that all residues fall into either α-helical region or in generously allowed region and stays well around the initial structure. Since the flexibilities increase at both ends of the peptide a lot, it shows only values for the residues from 26 to 34. Residues which satisfy helical conformations in the initial structures in TFE/water solutions are plotted in Figure 3B and the rest of the residues are plotted in Figure 3A . In Figure 3B , Φ, Ψ angles from the residues for Ala 30 , Ile 31 , Ile 32 , and Gly 33 retains α-helical structures well and located in the most favored regions for α-helical structure in Φ, Ψ plot during MD simulations.
Hydrogen bonds in Aβ25-35. Major factors for protein stabilization are hydrogen bonds, which play an important role in the folding process. For the stability of helix, the backbone hydrogen bond, C=OÎH-N (i-i+4), between amino acid i and amino acid i+4 are crucial. The distance between the donor-acceptor should be less than 2. , which is not in the helical region, i-i+2 connectivity observed in NMR experiments was maintained during the MD simulations as shown in Figure 4 . Figure 5 shows that distance time course for the intermolecular distances between Aβ25- 35 Figure 5 . In mixed co solvents of water and TFE, the properties will be intermediate between those of the two pure solvents. Therefore, the TFE concentration increases, charge interactions in peptide might be expected to become more important due to a lowering of the dielectric constant. The relative stabilities of the hydrogen bonds, C=OÎH-N (i-i+4) in the α-helix might also be changed by the solvent composition. A breaking of hydrogen bonds of the peptide backbone, which is characterized by the insertion of the water molecules, was not observed during the simulations. As shown in Figure 6 , there are hydrogen bonds between OH group of TFE and peptide backbone as well as those between the peptide backbone atoms. C=O of Ala 30 form bifurcated hydrogen bonds with O-H of TFE 6 as well as with N-H of Leu 34 .
Conclusion
CD measurement in our previous study indicates that Aβ25-35 in SDS micelle adopts β-sheet conformation at pH 4. 13 Previous CD studies in phospholipid vesicles 21 also describe that Aβ25-35 exhibits a reversible random coil ↔ β-sheet structure induced by negatively charged vesicles. In contrast, in TFE/water solution, Aβ25-35 forms a stable alpha-helical conformation from 30 to 35. 13 Water molecule destabilizes the α-helix in the peptide due to the strong interactions between the charged atoms in peptide and water. Dielectric constant of TFE is about one-third that of water, resulting in a strengthening of interactions between charged groups in the peptides. TFE is much weaker base than water resulting in a weaker capacity for accepting protons in hydrogen bonds. TFE has only one O-H group and has a much larger size than water. TFE/water mixed solvent has reduced capacity for forming hydrogen bond to the peptide compared to pure water solvent. Therefore, TFE forms hydrogen bonds to Aβ25-35 and allows Aβ25-35 to maintain the intramolecular hydrogen bond. In conclusion, α-helical secondary structure elements in Aβ25-35 determined from NMR spectroscopy in TFE/water mixed solvent are preserved during the MD simulation. TFE allows the peptide to form bifurcated hydrogen bonds to TFE as well as to peptide itself. MD simulation in this study supports the notion that TFE acts an α-helical structure forming solvent. Since it is important to develop a tool to control the amyloid deposition observed in Alzheimers disease patients, it will be meaningful to study how to manipulate the condition to promote the α-helical conformation of Aβ25-35. 
